Mark A Hallman

Mark A Hallman

Fox Chase Cancer Center - Philadelphia / United States
Medical and Health Sciences / Pharmacology
AD Scientific Index ID: 4619028
-
person_outline Mark A Hallman's MOST POPULAR ARTICLES
1-) Therapeutic management options for stage III non-small cell lung cancerSM Yoon, T Shaikh, M HallmanWorld journal of clinical oncology 8 (1), 1, 20171992017
2-) Effects of active and inactive phospholipase D2 on signal transduction, adhesion, migration, invasion, and metastasis in EL4 lymphoma cellsSM Knoepp, MS Chahal, Y Xie, Z Zhang, DJ Brauner, MA Hallman, ...Molecular pharmacology 74 (3), 574-584, 2008782008
3-) Comparison of outcomes and toxicities among radiation therapy treatment options for prostate cancerNG Zaorsky, T Shaikh, CT Murphy, MA Hallman, SB Hayes, ML Sobczak, ...Cancer treatment reviews 48, 50-60, 2016632016
4-) Prostate cancer patients with unmanaged diabetes or receiving insulin experience inferior outcomes and toxicities after treatment with radiation therapyNG Zaorsky, T Shaikh, K Ruth, P Sharda, SB Hayes, ML Sobczak, ...Clinical genitourinary cancer 15 (2), 326-335. e3, 2017542017
5-) Regulation of dedifferentiation and redifferentiation in renal proximal tubular cells by the epidermal growth factor receptorMA Hallman, S Zhuang, RG SchnellmannJournal of Pharmacology and Experimental Therapeutics 325 (2), 520-528, 2008532008